安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Dren Bio
Dren Bio is a privately held, clinical-stage biopharmaceutical company pioneering the discovery and development of novel antibody therapeutics that selectively deplete pathogenic cells and other disease-causing agents
- Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell . . .
Dren Bio is a privately held, clinical-stage biopharmaceutical company pioneering the discovery and development of novel first-in-class antibody therapeutics for the treatment of cancer, autoimmune, and other serious diseases
- Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next . . .
Dren Bio is a privately held, clinical-stage biopharmaceutical company pioneering the discovery and development of novel first-in-class antibody therapeutics for the treatment of cancer
- Sanofi signs $1. 9bn deal to buy Dren Bio autoimmune drug
Sanofi buys a drug from Dren Bio to claim a stake in the emerging field of deep B-cell depletion for autoimmune diseases
- Sanofi outlays $1. 9bn to purchase Dren Bio’s bispecific antibody
Sanofi is continuing its immunology pipeline push with an agreement to acquire Dren Bio’s bispecific antibody DR-0201 in a deal whose value could rise to $1 9bn
- Novartis pens $150M upfront bispecifics deal with Dren Bio
Under the terms of this partnership, Bay Area-based Dren Bio and Novartis will collaborate on discovering and developing new bispecific antibodies for cancer using Dren Bio’s Targeted
- Sanofi to pay Dren Bio up to $1. 7 billion to develop autoimmune disease . . .
Private biotech company Dren Bio has entered into a strategic collaboration with French drugmaker Sanofi to develop therapies for autoimmune diseases in a deal worth up to $1 7 billion, it said
- Sanofi returns to Dren Bio for another B cell depletion therapy at . . .
For Dren, Sanofi marks its third pharma partner The startup has engaged in dealmaking multiple times since its unveiling in 2020 It’s lined up Pfizer and Novartis in deals worth more than $1 billion and $3 billion, respectively, if all goes to plan
|
|
|